The origin of vaccine development for furunculosis may be traced to the work of Duff (1942) , who used an orally administered chloroform-inactivated suspension of whole cells and successfully protected cutthroat trout Oncorhynchus clarkii. Subsequent work rarely equaled or surpassed this original study (see Austin and Austin 1999) . Goldfish Carassius auratus may become infected with so-called atypical Aeromonas salmonicida, which leads to the development of unsightly ulcers . Often, the ulcers are populated with mixed cultures in which motile aeromonads, typically identified as A. hydrophila, are common . There is a lack of evidence of synergism between bacterial groups leading to exacerbated disease, and these motile aeromonads may be secondary invaders of ulcerated tissue . Previous work to develop vaccines for the control of ulcer disease of cyprinids has met with mixed success (e.g., Kozinska and Guz 2004) , often because of the lack of a reproducible challenge method . With the current success in salmonids of formalin-inactivated A. salmonicida preparations (e.g., Durbin et al. 1999) , we considered it timely to reexamine the potential of vaccines for controlling ulcer disease in ornamental fish.
Methods
Source of bacterial cultures.-One hundred eighty-three live, ulcerated ornamental fish-goldfish and koi carp Cyprinus carpio-were received from wholesale and retail outlets in England. The fish were killed by overdose with anesthetic (MS-222; Sigma, Basingstoke, UK) and, using flamesterilized scalpels, we cut into the muscle leading away from the ulcers. Loopfuls of material were spread over the surface of 5% (volume basis [v/ v] ) horse blood in nutrient agar, 5% (v/v) sheep blood in nutrient agar, and tryptic soy agar (TSA; all materials from Oxoid, Basingstoke, UK) and incubated room temperature (18-20ЊC) for 7 d. Plates with dense growth representing no more than two dominant colony types were examined further, and pure cultures were obtained by streaking and restreaking on fresh media. Thus, 42 pure cultures were obtained, which we equated with A. bestiarum (7 cultures) and A. salmonicida (35 cultures) after comparing with published characteristics (Ali et al. 1996; Austin et al. 1998 (Austin and Austin 1989 ) and used only stocks deemed to be healthy and, in particular, free of ulceration in subsequent experiments.
Vaccines.-A commercial vaccine against A. salmonicida (Furovac 5; Schering Plough Aquaculture Division, Saffron Walden, UK) was used with and without supplementation with formalininactivated (to 0.2% [v/v] with incubation at room temperature for 7 d) cells of A. bestiarum ORN2, atypical A. salmonicida ORN6, or both. Additional preparations were based exclusively on the laboratory-produced inactivated cell suspensions, and the formulated products contained equal numbers of cells of each component (Table 1 ). The cultures were grown for 48 h at room temperature in TSB with or without 0.1 mM dipyridyl (Sigma) to induce iron-deficient conditions and the production of iron-regulated outer membrane proteins (IROMPs) (Durbin et al. 1999) or with 0.1 mM ferric chloride (Sigma) for iron supplementation. Additionally, ORN6 was repeatedly subcultured every 7 d with incubation at 30ЊC to induce the development of nonautoagglutinating smooth cultures , which we used to produce vaccines. After inactivation with formalin, the cultures were checked for inactivation by inoculating 1.0-mL volumes into 9.0 mL of TSB and incubating at room temperature for 7 d. Then, 0.1-mL volumes of this incubated material were spread over the surface of triplicate plates of TSA and further incubated for up to 7 d at room temperature. The absence of growth was used as an indication of inactivation. The formalin-treated cultures were stored in the original inactivated growth medium at 4ЊC until required.
Vaccination regimes.-Groups of 100 goldfish were vaccinated by immersion or orally, and 28 d after the initial procedure were treated with or without immersion or oral booster doses. For immersion vaccination, we diluted the stock vaccine in tank water to about 5 ϫ 10 7 cells/mL, as determined by reading a sample on a hemocytometer slide (Improved Neubauer type; Merck, Lutterworth, UK) at a magnification of 400ϫ on an Axiophot microscope (Carl Zeiss, Welwyn Garden City, UK). The fish were immersed in this diluted vaccine for 60 s before being returned to the holding tanks. For oral vaccination, we mixed the vaccine with an equal volume of oralizer (Schering Plough Aquaculture; International Patent WO 92/ 06599) that contained fish oil and emulsifying agent. We emulsified the mixture at high-shear forces for 20 min in a Silverson (Waterside, Chesham, UK) homogenizer, and then mixed this emulsion with commercial pelleted feed to achieve a dose equivalent to 5 ϫ 10 7 cells/g of feed. This preparation was fed on demand to the fish, three times daily for 7 d, such that each fish received about 1.0 g of feed in total. Additional feeding on demand was with the same commercial pelleted feed, minus the added emulsion. Each vaccination procedure was carried out once for each set of experiments, but over the course of the work, the vaccines were evaluated four times.
Challenge experiments.-The fish were chal-205 VACCINE FOR ULCER DISEASE lenged 28 d after initial vaccination or booster with atypical A. salmonicida ORN6a by intramuscular injection of this organism at 2 ϫ 10 2 cells/fish. Preliminary experiments revealed that this was the equivalent of an LD80 dose (the dose at which 80% of infected fish died), with an outcome of ulceration and mortality. Thus, we grew the infectious culture overnight at room temperature in TSB, centrifuged it (4000 ϫ g at 4ЊC for 15 min), washed it twice, resuspended it in 0.9% (w/v) saline, and determined the cell count of the culture by viewing on a hemocytometer slide (Improved Neubauer Type) at a magnification of 400ϫ on a Carl Zeiss Axiophot microscope. The fish were examined daily for 21 d, and the number of mortalities recorded and used to calculate the relative percent survival (RPS; Amend 1981). We examined dead and moribund fish microbiologically to confirm the presence of atypical A. salmonicida (Austin et al. 1998) .
Statistics.-Quantitative data were examined by a range of statistical methods, including the calculation of standard deviations, Student's t-test, and the Mann-Whitney test (Steele and Torrie 1981) , contained on the INSTAT 2.01 for Macintosh software (GraphPad Software, San Diego, California). We used the parametric Student's ttest to examine all immunology data.Where the data did not follow Gaussian distribution patterns, we also used the nonparametric Mann-Whitney test to determine statistical significance.
Immunology.-The methods used to examine changes in immunological parameters after vaccination have been described elsewhere (Irianto and Austin 2002) . In brief, blood was collected from freshly killed fish (10 fish per group) by venipuncture, and then diluted 10-fold and 100-fold in phosphate-buffered saline at pH 7.2 (PBS; Oxoid). We examine the diluted sample microscopically using a hemocytometer slide (Improved Neubauer Type) to determine the number of leukocytes and erythrocytes. We also examined blood films to determine the relative proportion of leukocytes, that is, of polymorphonuclear granulocytes, lymphocytes, and monocytes. The remainder of the blood was transferred to evacuated collection tubes containing clot-activating gel (Vacuettes; Greiner, Gloucester, UK), and allowed to clot by incubation at room temperature for 1 h, and stored overnight at 4ЊC. The serum obtained was then removed and stored atϪ70ЊC until required.
Lysozyme activity in serum samples was determined by the reduction in optical density at 570 nm of a suspension of Micrococcus luteus (formerly M. lysodeikticus) obtained from the National Collection of Industrial and Marine Bacteria (NCIMB, Aberdeen, UK; 9278) as described by Irianto and Austin (2002) . We also analyzed the serum samples with an enzyme-linked immunosorbent assay (ELISA) to determine the presence and titer of antibodies to atypical A. salmonicida ORN6 (Durbin et al. 1999) .
From the same fish we obtained the kidneys and used them to determine the relative proportion of dead and live macrophages and macrophage phagocytic activity (Irianto and Austin 2002) .
Results

Vaccination
The results revealed that the commercial furunculosis vaccine (Furovac 5) administered by immersion with or without an oral booster did not protect goldfish against mortalities when challenged with atypical A. salmonicida; the cumulative mortalities over 21 d corresponding to those of the controls (experiment 1; Table 2 ). Moreover, supplementing this vaccine with formalin-inactivated cells of ORN2 and ORN6, grown in conditions of iron-limitation, did not improve protection (experiment 2; Table 2 ). Indeed, for fish immersed in the iron-limited and iron-supplemented preparations, the cumulative mortalities exceeded those of the controls (experiment 2; Table 2 ). Yet supplementing the commercial vaccine with ironlimited and iron-supplemented preparations improved the benefit of immersion vaccination followed by an oral booster after 28 d (Table 2) , the cumulative mortalities being less than those of the controls (experiment 2; Table 2 ). Consequently, we focused solely on vaccines based exclusively around isolates recovered from ornamental fish. Using formalin-treated cells of atypical A. salmonicida ORN6 that had been grown in either ironlimited or iron-supplemented conditions was not successful when administered only by immersion, in comparison with the controls (experiment 3; Table 2 ). Similarly, a mixture of A. bestiarum ORN2 and atypical A. salmonicida ORN6 cells prepared in iron-limited and iron-supplemented conditions was not effective when administered to goldfish solely by immersion (experiment 4; RPS ϭ 1%; Table 2 ). But the administration of an oral booster to goldfish after immersion vaccination substantially improved protection (experiment 4; RPS ϭ 81%; Table 2 ). Here, the cumulative mortality among the vaccinated fish was only16%, compared with 84% total mortalities in the con- 
a Smooth isolate.
trols after 21 d (experiment 4; Table 2 ). Replacing the iron-limited or iron-supplemented ORN2 component with cells grown in TSB was generally superior; treatment with this preparation after immersion vaccination and challenge improved the protection of goldfish in that the RPS increased from 62% to 91% (experiment 5; Table 2 ). The use of ORN2 and ORN6 grown only in TSB gave only moderate levels of protection when administered by immersion with or without an oral booster. When immersion only was used, an RPS of 51% was recorded (experiment 6; Table 2 ). In a separate experiment, iron-limited and iron-supplemented cells of ORN6 (used separately and in combination) plus cells of ORN2 grown in TSB were used to vaccinate fish by immersion followed by an oral booster with the homologous oralized product. After challenge, 98 unvaccinated controls died compared with 4 in the group that received the iron-limited and iron-supplemented cells of ORN6 (RPS ϭ 96%), 37 of the group that received iron-limited cells of ORN6 by immersion and an oral booster (RPS ϭ 62%), and 44 of the group that received iron-supplemented cells of ORN6 by immersion and an oral booster (RPS ϭ 55%), Consistently over four replicate experiments, we found that the use of formalin-inactivated cells of atypical A. salmonicida ORN6 grown in iron-limited and iron-supplemented conditions together with A. bestiarum grown in TSB when applied by immersion with an oral booster provided excellent protection (Table 2 ). In one experiment, an RPS of 96% was achieved (experiment 7; Table 2); that is, only 4% of the vaccinated fish died, compared with 99% of the controls. Moreover, the surviving vaccinated fish were completely devoid of ulcers. Parallel results were obtained in replicates, with RPS values ranging from 96% to 99% (experiment 7-8). Application of the vaccine solely by the oral route was less successful in that a primary (oral) vaccination led to 68 mortalities (RPS ϭ 12%), whereas an oral booster was only marginally better, with 58 mortalities (RPS ϭ 25%). In comparison, only 6 mortalities (RPS ϭ 92%) occurred when the vaccine was administered by immersion and an oral booster, but the unvaccinated controls 207 VACCINE FOR ULCER DISEASE TABLE 3.-Numbers of erythrocytes and leucocytes and phagocytic and lysozyme activity (Ϯ SDs) in goldfish (group size ϭ 50; average length ϭ 6 cm) after administering iron-limited and iron-supplemented preparations of ORN6 and cells of ORN2 grown in TSB by immersion followed by an oral booster; see Table 1 for abbreviations. The fish were examined on the same day as challenge, 28 d after feeding the oral booster. P-values are given in parentheses; differences are considered statistically significant when P Ͻ 0.05. TABLE 4.-Proportion (%) of lymphocytes, monocytes, and polymorphonuclear granulocytes in goldfish blood (average fish length ϭ 6 cm) after administering iron-limited and iron-supplemented preparations of ORN6 and cells of ORN2 grown in TSB by immersion, followed by an oral booster; see Table 1 for abbreviations. The fish were examined on the same day as challenge, 28 d after feeding the oral booster. P-values are given in parentheses; differences are considered statistically significant when P Ͻ 0.05. had 77 mortalities. Interestingly, a smooth derivative of ORN6 was less successful than the original rough isolate, yielding RPS values of 65% and 93%, respectively (experiment 8; Table 2 ). The use of formalin-inactivated cells of atypical A. salmonicida ORN6 grown in iron-limited and ironsupplemented conditions, together with A. bestiarum grown in TSB applied orally with or without an oral booster, was less successful than when applied by immersion followed by an oral booster (experiment 9; Table 2 ).
Immunology
The following data were obtained by using formalin-inactivated cells of atypical A. salmonicida ORN6 grown in iron-limited and iron-supplemented conditions and A. bestiarum grown in TSB, when applied by immersion with an oral booster. Thus by ELISA, serum antibodies to atypical A. salmonicida were detected by the time of challenge in vaccinated fish. Low antibody titers of 1:19-1: 99 were consistently recorded among the unvaccinated control goldfish. Titers of 1:39-1:396 were found in the fish that had been vaccinated by immersion (followed by an oral booster) with ironlimited and iron-supplemented preparations of atypical A. salmonicida ORN6, or with cells of A. bestiarum ORN2 grown in TSB. In contrast, use of Furovac 5 resulted in antibody titers among the vaccinated fish of 1:4-1:99, that is, similar to those of the unvaccinated controls.
Tables 3 and 4 present data for the numbers of erythrocytes and leukocytes; the proportion of phagocytosing macrophages; the relative proportions of lymphocytes, monocytes, and polymorphonuclear cells; and the lysozyme activity. Generally, immersion vaccination and oral boosting with iron-restricted and iron-supplemented cells of atypical A. salmonicida ORN6 and the preparation of A. bestiarum ORN2 in TSB, goldfish demonstrated more leukocytes, (1.3 Ϯ 1.9) ϫ 10 7 /mL, than did the controls, (0.4 Ϯ 0.2) ϫ 10 7 /mL (Table  3) , although these data were not regarded as statistically significant (P ϭ 0.7302, Mann-Whitley test). Similarly, a higher proportion of dead macrophages, which did not appear to be necrotic or apoptotic, were recorded for vaccinated fish (10.9 Ϯ 3.5%) than for the controls (6.8 Ϯ 3.1%), a difference that was statistically significant (P ϭ 0.0149, Student's t-test). Incidentally, all the kidneys appeared to be in good condition, devoid of any visual signs of damage or disease. The number of erythrocytes was similar between vaccinates and controls (Table 3) , with differences that were not statistically significant (P ϭ 0.9283, Student's t-test). Furthermore, the levels of phagocytic macrophages (P ϭ 0.2774), lysozyme activity (P ϭ 0.3843), and the proportion of lymphocytes (P ϭ 0.5841), monocytes (P ϭ 0.3154), and polymorphonuclear granulocytes (P ϭ 0.7096) in vaccinated and control fish were not regarded as statistically different (Table 3 and 4) .
Discussion
The data reveal that a vaccination strategy may be used successfully to combat mortalities result-208 ROBERTSON ET AL. ing from infection with atypical A. salmonicida in goldfish. As such, our findings lend support to the previously stated view that vaccines containing atypical A. salmonicida cells may be beneficial when confronting disease attributed to these strains, insofar as commercial products developed with typical strains for salmonids are generally not effective (Lund et al. 2002) . Certainly, there are indications that vaccines prepared with atypical isolates of A. salmonicida are successful; for example, the RPS of about 90% achieved in Atlantic halibut and spotted wolffish (Ingilae et al. 2000) is compatible with that achieved for ornamental fish in this study. Thus, there are parallels with the perceived benefits of autogenous vaccines (Gudmundsdó ttir et al. 2003) , in this case containing atypical A. salmonicida from the actual host. Similar to previous studies, our data point to the value of virulent (i.e., rough) cells of A. salmonicida for conferring greater protection than the smooth variant (Lund et al. 2003) . Indeed, the A-layer of an atypical isolate of A. salmonicida has been determined to be immunogenic for goldfish (Sinyakov et al. 2001 ). However, the most successful vaccination regime involved cells of atypical A. salmonicida grown in conditions of iron restriction and iron supplementation together with cells of A. bestiarum grown on standard bacteriological medium (e.g., TSB) administered by an initial immersion followed by an oral booster. The approach is in agreement with previous studies with salmonids, when protection was enhanced after administration of an oral booster (Thorburn and Jansson 1988; Midtlyng et al. 1996) . Moreover, Arijo et al. (2003) reported significantly increased protection in sea bream after booster vaccination, which they attributed to increased levels of antibody against bacterial lipopolysaccharides. Furthermore, the value of oral vaccination for stimulation of specific antibody production and innate cellular immunity has been well recognized (e.g., Durbin et al. 1999) .
Aeromonas bestiarum, a recent addition to the range of fish pathogens (Kozinska and Guz 2004) , may be beneficial as a component of the vaccine because of a possible immunostimulatory role, such as by means of lipopolysaccharide (Loghothetis and Austin 1996) and the presence of shared antigens with other bacterial species (Swain et al. 2003) . Indeed, polyvalent vaccines have shown greater protection against A. salmonicida infections in Atlantic salmon than have monovalent preparations (Hoel et al. 1998; Lund et al. 2003) .
The nature of the protection may well involve antibody production (Bricknell et al. 1999 ) and stimulation of innate immunity (Irianto and Austin 2002) . Other workers have pointed to a greater correlation between protection and antibody titer (Bricknell et al. 1999 ) than we inferred in this investigation. However, any specific antibody response may take many weeks to develop and lead to protection, whereas innate mechanisms are activated within days (Ellis 2001) . Thus, innate defense mechanisms might well be more important than previously realized. In this study, we found a statistically significant difference between vaccinated fish and controls regarding the number of head kidney macrophages absorbing trypan blue. Furthermore, although not statistically significant, the vaccinated fish had an increase in the number of leukocytes compared with the controls, which agrees with earlier work on probiotics (Irianto and Austin 2003) .
In conclusion, the use of a polyvalent vaccine by immersion and an oral booster can protect goldfish against ulcer disease. However, it remains for further work to determine the precise duration of protection.
